The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated findings of a first-in-human, phase I study of margetuximab (M), an Fc-optimized chimeric monoclonal antibody (MAb), in patients (pts) with HER2-positive advanced solid tumors.
 
Howard A. Burris
No Relationships to Disclose
 
Giuseppe Giaccone
Consulting or Advisory Role - Astex Pharmaceuticals; AVEO; Boehringer Ingelheim; Clovis Oncology
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Novartis; Roche Pharma AG
Research Funding - AstraZeneca
 
Todd Michael Bauer
Research Funding - Macrogenics (Inst)
 
Do-Youn Oh
Consulting or Advisory Role - Bayer; Merck; Novartis
 
Suzanne Fields Jones
Research Funding - Macrogenics (Inst)
 
Jeffrey L. Nordstrom
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Hua Li
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
David A Carlin
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Jan E. Baughman
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Robert Joseph Lechleider
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Consulting or Advisory Role - Geron
 
Yung-Jue Bang
Research Funding - Macrogenics (Inst)